EPS Phase 4 is an advancement that allows Electronic Prescriptions to be the default mode of prescribing in primary care, even for patients without a nominated pharmacy. Here are the key features and benefits:
Key Features of EPS Phase 4
- **No Nomination Required:** If a patient does not nominate a pharmacy, they receive an EPS token. This token can be taken to a pharmacy, which then downloads the prescription electronically.
- **Electronic Signing:** Prescriptions are digitally signed using a smartcard, eliminating the need for a wet signature.
- **Reduced Paper Use:** The number of paper prescriptions decreases significantly as prescriptions are sent electronically.
- **Improved Prescription Tracking:** Using the EPS tracker, prescriptions can be audited, reducing the risk of lost prescriptions.
Benefits for Different Stakeholders
- **Practices:** Less time spent handling paper prescriptions, reduced patient footfall collecting prescriptions, and enhanced workflow efficiency.
- **Pharmacies:** They can prepare prescriptions in advance as they have visibility of incoming prescriptions before patients arrive, decreasing wait times.
- **Patients:** Ability to choose their preferred pharmacy for collection, less time spent obtaining prescriptions, and greater privacy with electronic handling.
"The introduction of EPS Phase 4 significantly reduces prescription loss and administrative burden, saving time for both clinicians and pharmacists."
